Near Vision Impairment and Frailty: Evidence of an Association.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
12 2019
Historique:
received: 21 06 2019
revised: 16 08 2019
accepted: 16 08 2019
pubmed: 30 8 2019
medline: 28 3 2020
entrez: 30 8 2019
Statut: ppublish

Résumé

To examine associations between near vision impairment (NVI) and frailty. Cross-sectional study. Setting: Nationally representative sample of noninstitutionalized United States civilians. Total of 2705 older adults aged ≥60 years from National Health and Nutrition Examination Survey (1999-2002). Presenting NVI (PNVI): near acuity worse than 20/40. Self-reported NVI (SNVI): self-reported difficulty with near vision tasks. Five-item physical frailty index; participants classified as frail (≥3 criteria) and prefrail (1 or 2 criteria). Propensity score-adjusted and probability-weighted multinomial multivariable logistic regression was used to examine associations of PNVI and SNVI with frailty. Of 2705 participants, 381 (10%), 160 (5%), and 106 (3%) had PNVI only, SNVI only, and PNVI+SNVI, respectively. In fully adjusted models, as compared to those without PNVI, participants with PNVI were more likely to be prefrail (odds ratio [OR] = 1.6; 95% confidence interval [CI] = 1.1, 2.3) and frail (OR = 2.5; 95% CI = 1.4, 4.3). As compared to those without SNVI, participants with SNVI were more likely to be prefrail (OR = 2.9; 95% CI = 1.8, 4.7) and frail (OR = 4.3; 95% CI = 2.2, 8.3). As compared to those without PNVI or SNVI, participants with PNVI+SNVI were more likely to be prefrail and frail (prefrail: OR = 4.0; 95% CI = 2.2, 7.2 and frail: OR = 4.5; 95% CI = 1.7,12.7). Older adults with PNVI and SNVI were more likely to be prefrail and frail than those without respective NVI, suggesting that NVI is associated with frailty.

Identifiants

pubmed: 31465753
pii: S0002-9394(19)30401-5
doi: 10.1016/j.ajo.2019.08.009
pmc: PMC6888870
mid: NIHMS1538289
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

234-241

Subventions

Organisme : NIA NIH HHS
ID : K01 AG052640
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG021334
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Stat Methods Med Res. 2013 Jun;22(3):278-95
pubmed: 21220355
Arch Gerontol Geriatr. 2015 May-Jun;60(3):464-70
pubmed: 25697060
Am J Ophthalmol. 2017 Feb;174:134-144
pubmed: 27865728
JAMA Ophthalmol. 2019 Apr 1;137(4):391-398
pubmed: 30676634
Am J Ophthalmol. 2012 Jul;154(1):107-116.e1
pubmed: 22534109
Ophthalmology. 2013 Sep;120(9):1736-44
pubmed: 23664469
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2797-802
pubmed: 16799016
J Nutr Health Aging. 2016;20(8):870-877
pubmed: 27709237
J Am Med Dir Assoc. 2014 Sep;15(9):635-42
pubmed: 24746590
Arch Ophthalmol. 2001 Jul;119(7):1050-8
pubmed: 11448327
J Am Geriatr Soc. 1999 Nov;47(11):1319-25
pubmed: 10573440
Arch Ophthalmol. 2003 Nov;121(11):1577-81
pubmed: 14609914
Trans Am Ophthalmol Soc. 2003;101:191-6; discussion 196-9
pubmed: 14971577
J Gerontol A Biol Sci Med Sci. 2019 Aug 16;:null
pubmed: 31419280
Ophthalmology. 2006 May;113(5):728-34
pubmed: 16650665
Ophthalmology. 2006 Dec;113(12):2209-12
pubmed: 16996595
J Epidemiol Community Health. 2017 Nov;71(11):1053-1058
pubmed: 28798152
Ophthalmology. 2003 Apr;110(4):644-50
pubmed: 12689880
Ophthalmology. 2004 Jun;111(6):1132-40
pubmed: 15177963
Invest Ophthalmol Vis Sci. 2011 Jun 13;52(7):4118-23
pubmed: 21508106
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Am J Ophthalmol. 2005 Jul;140(1):129-31
pubmed: 16038655
Ophthalmology. 1999 May;106(5):904-9
pubmed: 10328388
JBI Database System Rev Implement Rep. 2018 Jan;16(1):140-232
pubmed: 29324562
J Am Geriatr Soc. 2005 Apr;53(4):681-6
pubmed: 15817017
Optom Vis Sci. 1996 Apr;73(4):235-42
pubmed: 8728490
Lancet Glob Health. 2017 Sep;5(9):e888-e897
pubmed: 28779882
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4103-9
pubmed: 19357359

Auteurs

Varshini Varadaraj (V)

Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Moon Jeong Lee (MJ)

Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Jing Tian (J)

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Pradeep Y Ramulu (PY)

Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Karen Bandeen-Roche (K)

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Bonnielin K Swenor (BK)

Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Electronic address: bswenor@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH